{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:11:28Z","timestamp":1760058688885,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019780","name":"Chonnam National University, Hwasun Hospital Institute for Biomedical Science","doi-asserted-by":"publisher","award":["HCRI24021"],"award-info":[{"award-number":["HCRI24021"]}],"id":[{"id":"10.13039\/501100019780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Elevated expression of human epididymis protein 4 (HE4) has been observed in breast cancer and is associated with cancer progression; however, its role in ductal carcinoma in situ (DCIS) remains unclear. This study aimed to evaluate HE4 levels in serum and tissue from patients with DCIS and their correlation with clinicopathological features. Methods: Preoperative serum HE4 levels were measured in 59 DCIS patients. HE4 mRNA and protein expression in DCIS and adjacent normal tissues were assessed using RNAscope in situ hybridization and immunohistochemistry, respectively. An additional independent tissue microarray of 41 DCIS cases was also analyzed for HE4 expression in tumor tissue only. Furthermore, the BreastMark database was applied to assess the prognostic significance of HE4 expression in a larger cohort of breast cancer. Results: Serum HE4 levels (mean \u00b1 SD: 39.4 \u00b1 11.9 pmol\/L) were within the normal range and showed no significant correlation with clinicopathological parameters except menopausal status. HE4 expression was significantly higher in DCIS tissues compared to adjacent normal tissues, with a positive correlation between mRNA and protein levels (r = 0.771, p &lt; 0.001). High HE4 mRNA and protein expression was associated with ER positivity, HER2 negativity, low stromal tumor-infiltrating lymphocyte density, and HR+\/HER2\u2212 subtypes, but was not predictive of DCIS recurrence. In breast cancer patients, high HE4 expression was significantly correlated with improved survival outcomes. Conclusions: Although serum HE4 is not elevated in DCIS, high HE4 expression in tissue is associated with favorable clinicopathological features. These findings highlight the need for further investigation into the potential prognostic role of HE4.<\/jats:p>","DOI":"10.3390\/diagnostics15091058","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:11:48Z","timestamp":1745352708000},"page":"1058","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Human Epididymis Protein 4 Expression in Breast Ductal Carcinoma In Situ"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6215-8549","authenticated-orcid":false,"given":"Nah Ihm","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pathology, Chonnam National University Medical School, Gwangju 61469, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Ho","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Chonnam National University Medical School, Gwangju 61469, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-2228","authenticated-orcid":false,"given":"Ji Shin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chonnam National University Medical School, Gwangju 61469, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"ref_1","unstructured":"Allison, K.H., Brogi, E., Ellis, I.O., Fox, S.B., Morris, E.A., Sahin, A., Salgado, R., Sapino, A., Sasano, H., and Schnit, S.J. (2019). Ductal carcinoma in situ. WHO Classification of Tumors Editorial Board. Breast Tumours. WHO Classification of Tumors, IARC. [5th ed.]."},{"key":"ref_2","unstructured":"Hoda, S.A., Brogi, E., Koerner, F.C., and Rosen, P.P. (2021). Ductal carcinoma in situ. Rosen\u2019s Breast Pathology, Wolters Kluwer. [5th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4048\/jbc.2024.0213","article-title":"Breast cancer statistics in Korea, 2021","volume":"27","author":"Cha","year":"2024","journal-title":"J. Breast Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Panico, A., Gatta, G., Salvia, A., Grezia, G.D., Fico, N., and Cuccurullo, V. (2023). Radiomics in breast imaging: Future Development. J. Pers. Med., 13.","DOI":"10.3390\/jpm13050862"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"James, N.E., Chichester, C., and Ribeiro, J.R. (2018). Beyond the biomarker: Understanding the diverse roles of human epididymis protein 4 in the pathogenesis of epithelial ovarian cancer. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00124"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chudecka-G\u0142az, A., Strojna, A., Michalczyk, K., Wieder-Huszla, S., Safranow, K., Skwirczy\u0144ska, E., and Jurczak, A. (2023). Evaluation of HE4 use in the diagnosis of ovarian Cancer: First and second recurrence, and an analysis of HE4 concentration during second- and third-line chemotherapy. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030452"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lou, Y., Jiang, F., Du, Y., and Guan, J. (2024). Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1442127"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14737159.2018.1457436","article-title":"Prognostic value of serum and tissue HE4 expression in ovarian cancer: A systematic review with meta-analysis of 90 studies","volume":"18","author":"Cao","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_11","first-page":"4017","article-title":"High expression and potential synergy of human epididymis protein 4 and Annexin A8 promote progression and predict poor prognosis in epithelial ovarian cancer","volume":"12","author":"Zhu","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5468\/ogs.23024","article-title":"Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer","volume":"66","author":"Uno","year":"2023","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1515\/cclm-2012-0097","article-title":"Human epididymis protein 4 (HE4) in benign and malignant diseases","volume":"50","author":"Hertlein","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/RCT.0000000000000390","article-title":"The use of breast magnetic resonance imaging parameters to identify possible signaling pathways of a serum biomarker, HE4","volume":"40","author":"Karaman","year":"2016","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/mco.2016.919","article-title":"A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study","volume":"5","author":"Gunaldi","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/CBM-160024","article-title":"Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer","volume":"18","author":"Lu","year":"2017","journal-title":"Cancer Biomark."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.31557\/APJCP.2021.22.8.2509","article-title":"Serum human epididymis protein-4 (HE4)\u2014A novel approach to differentiate malignant from benign breast tumors","volume":"22","author":"Rehman","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.30699\/ijp.2021.135323.2482","article-title":"HE4, A new potential tumor marker for early diagnosis and predicting of breast cancer progression","volume":"16","author":"Abdollahi","year":"2021","journal-title":"Iran J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12282-021-01328-8","article-title":"BC-DETECT: Combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy","volume":"29","author":"Abdelrazek","year":"2022","journal-title":"Breast Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_21","first-page":"4779","article-title":"HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer","volume":"30","author":"Kamei","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/IJPM.IJPM_465_17","article-title":"Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer","volume":"61","author":"Akoz","year":"2018","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_23","unstructured":"Lee, J.S., Kim, N.I., and Park, M.H. (2024, January 7\u201310). Assessment of human epididymis protein four expression in ductal carcinoma in situ of the breast [abstract]. Proceedings of the 2024 European Congress of Pathology, Florence, Italy. Abstract nr PS-02-019."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kim, G.E., Kim, N.I., Park, M.H., and Lee, J.S. (2018). B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Tumour Biol., 40.","DOI":"10.1177\/1010428318815032"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/PAI.0b013e318235a132","article-title":"Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors","volume":"20","author":"Kim","year":"2012","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/134.6.907","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: Recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/bcr3444","article-title":"BreastMark: An integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome","volume":"15","author":"Madden","year":"2013","journal-title":"Breast Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","article-title":"Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients","volume":"104","author":"Bignotti","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Behrouzi, R., Ryan, N.A.J., Barr, C.E., Derbyshire, A.E., Wan, Y.L., Maskell, Z., Stocking, K., Pemberton, P.W., Bolton, J., and McVey, R.J. (2020). Baseline serum HE4 but not tissue HE4 expression predicts response to the Levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer. Cancers, 12.","DOI":"10.3390\/cancers12020276"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41379-019-0204-1","article-title":"Ductal carcinoma in situ of the breast: An update for the pathologist in the era of individualized risk assessment and tailored therapies","volume":"32","author":"Hanna","year":"2019","journal-title":"Mod. Pathol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/9\/1058\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:14Z","timestamp":1760030354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/9\/1058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["diagnostics15091058"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15091058","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}